1. Home
  2. SUPN vs GEO Comparison

SUPN vs GEO Comparison

Compare SUPN & GEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • GEO
  • Stock Information
  • Founded
  • SUPN 2005
  • GEO 1984
  • Country
  • SUPN United States
  • GEO United States
  • Employees
  • SUPN N/A
  • GEO N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • GEO Homebuilding
  • Sector
  • SUPN Health Care
  • GEO Consumer Discretionary
  • Exchange
  • SUPN Nasdaq
  • GEO Nasdaq
  • Market Cap
  • SUPN 1.8B
  • GEO 3.9B
  • IPO Year
  • SUPN 2012
  • GEO 1994
  • Fundamental
  • Price
  • SUPN $33.96
  • GEO $26.27
  • Analyst Decision
  • SUPN Hold
  • GEO Strong Buy
  • Analyst Count
  • SUPN 2
  • GEO 5
  • Target Price
  • SUPN $36.00
  • GEO $44.50
  • AVG Volume (30 Days)
  • SUPN 739.8K
  • GEO 3.2M
  • Earning Date
  • SUPN 08-05-2025
  • GEO 08-06-2025
  • Dividend Yield
  • SUPN N/A
  • GEO N/A
  • EPS Growth
  • SUPN N/A
  • GEO N/A
  • EPS
  • SUPN 1.11
  • GEO 0.23
  • Revenue
  • SUPN $667,997,000.00
  • GEO $2,422,677,000.00
  • Revenue This Year
  • SUPN N/A
  • GEO $8.47
  • Revenue Next Year
  • SUPN $12.02
  • GEO $26.55
  • P/E Ratio
  • SUPN $29.92
  • GEO $115.93
  • Revenue Growth
  • SUPN 11.82
  • GEO 0.50
  • 52 Week Low
  • SUPN $27.05
  • GEO $11.75
  • 52 Week High
  • SUPN $40.28
  • GEO $36.46
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 66.18
  • GEO 56.14
  • Support Level
  • SUPN $32.49
  • GEO $25.77
  • Resistance Level
  • SUPN $33.80
  • GEO $26.63
  • Average True Range (ATR)
  • SUPN 0.91
  • GEO 0.92
  • MACD
  • SUPN 0.23
  • GEO 0.35
  • Stochastic Oscillator
  • SUPN 99.37
  • GEO 78.09

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

Share on Social Networks: